Dr. Charles Rosser: Publication List (July, 2005)


Peer Reviewed Articles (in descending chronological order)
  1. Goodison S, Rosser CJ. Bladder Cancer Associated Glycoprotein Signatures revealed by Urinary Proteomic Profiling. (ACCEPTED in J Proteome Res.)
  2. Goodison S, Nakamura K, Iczkowski KA, Anai S, Boehlein SK, Rosser CJ.  Exogenous Mycoplasmal p37 Protein Alters Gene Expression, Growth, and Morphology of Prostate Cancer Cells.  (ACCEPTED in Cytogenetics and Genome Research.)
  3. Nakamura K, Kasraeian A, Yacoub SM, Pendleton JM, Anai S, Rosser CJ.  The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility.  (ACCEPTED in International Brazilian Journal of Urology.)
  4. Anai S, Tanaka M, Shiverick KT, Kim W, Takada S, Boehlein S, Goodison S, Mizokami A, Rosser CJ.  Increased expression of COX-2 correlates with resistance to Radiation in human prostate adenocarcinoma cells.  J Urol. 2007 May;177(5):1913-7.
  5. Anai S, Brown BD, Nakamura K, Goodison S, Hirao Y, Rosser CJ.  Irradiation of Human Prostate Cancer Cells Increases Uptake of Antisense Oligodeoxynucleotide.  Int J Radiat Oncol Biol Phys. (ACCEPTED in Int J Radiat Oncol Biol Phys.)
  6. Anai S, Goodison S, Shiverick K, Hirao Y, Brown BD, Rosser CJ.  Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts  Mol Cancer Ther 2007 6: 101-111.
  7. Namiki K, Rosser CJ. Neoadjuvant therapy and prostate cancer: what a urologist should know.  Curr Opin Urol. 2007 May;17(3):188-93.
  8. Rice L, Handayani R, Cui Y, Medrano T, Samedi V, Baker H, Szabo NJ, Rosser CJ, Goodison S, Shiverick KT. Soy Isoflavones Exert Differential Effects on Androgen Responsive Genes in LNCaP Human Prostate Cancer Cells.  J Nutr. 2007 Apr;137(4):964-972.
  9. Pendleton J, Pisters LL, Nakamura K, Anai S, Rosser CJ. Neoadjuvant therapy before radical prostatectomy: Where have we been? Where are we going?  Urol Oncol. 2007 Jan-Feb;25(1):11-8.
  10. Anai S, Goodison S, Shiverick K, Iczkowski K, Tanaka M, Rosser CJ. Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.  Hum Gene Ther. 2006 Oct;17(10):975-84.
  11. Pendleton J, Costa J, Wludyka P, Carvin DM, Rosser CJ. Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the prostate: a prospective, randomized, controlled trial.  J Urol. 2006 Oct;176(4 Pt 1):1372-5.
  12. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer.  Cancer. 2006 Aug 1;107(3):631-9.
  13. Rosser CJ, Kamat AM, Pendleton J, Robinson TL, Pisters LL, Swanson DA, Babaian RJ. Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy.  Cancer. 2006 Jul 1;107(1):54-9.
  14. Anai S, Pendleton J, Wludyka P, Williams C, Nelms L, Pettaway C, Rosser CJ. Prostate cancer screening and detection in inner-city and underserved men.  J Natl Med Assoc. 2006 Apr;98(4):515-9.
  15. Rosser CJ, Kamat AM, Wang X, Do KA, Naya Y, Hoover DC, Troncoso P, Sanches-Ortiz RF, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy.  Urology. 2006 Apr;67(4):769-73. Epub 2006 Apr 11.
  16. Leibovici D, Kamat AM, Pettaway CA, Pagliaro L, Rosser CJ, Logothetis C, Pisters LL. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer.  J Urol. 2005 Dec;174(6):2186-90.
  17. Rosser CJ, Parker A.:  The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?  J Urol.  2005 Sep;174(3):1154-5; author reply 1155-6.
  18. Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?  Urology.  2005 Aug;66(2):327-31.
  19. Ketcham CM, Anai S, Reutzel R, Sheng S, Schuster SM, Brenes RB, Agbandje-McKenna M, McKenna R, Rosser CJ, Boehlein SK.  P37 induces tumor invasiveness.  Mol Cancer Ther.  2005 Jul;4(7):1031-8.
  20. Tanaka M, Rosser CJ, Grossman HB.  PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.
    Cancer Detect Prev. 29:170-4, 2005.
  21. Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate carcinoma after radiation therapy.  Cancer. 103:2060-6, 2005.
  22. Leibovici D, Pagliaro L, Rosser CJ, Pisters LL. Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy.
    J Urol. 173:781-3, 2005.
  23. Rosser CJ, Tanaka N, Stafford RJ, Price RE, Hazle JD, Tanaka M, Kamat AM, Pisters LL.  Feasibility to delineate distribution of solution injected intraprostatic using an ex-vivo canine model.  Gene Ther Mol Biol.  8:509-514, 2004.
  24. Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway CA, Kamat AM, Chichakli R, Lee AK, Cheung RM, Sanchez-Ortiz, R, Pisters, LL. Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer.  J Natl Med Assoc. 2004 Jul;96(7):939-44.
  25. Kamat AM, Rosser CJ, Levy LB, Chichakli R, Lee AK, Cheung RM, Pisters LL. Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure.  Urology. 2004 Jun;63(6):1132-7.
  26. Sanchez-Ortiz R, Rosser CJ, Madsen LT, Swanson DA, Wood CG.  Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma.  J Urol. 2004 Jun;171(6 Pt 1):2160-5.
  27. Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonell TJ, Kuban DA, Meyn RA.  Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2 expressing prostate cancer cells to radiation.  Cancer Gene Therapy. Feb 2004.
  28. Kamat AM, Shock RP, Nara Y, Rosser CJ, Slaton JW, Pisters LL.  Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors.  Urology. 63:46, 2004.
  29. Rosser CJ, Kroovand RL. VURD syndrome managed by pyelostomy.
    ScientificWorldJournal. 4:382-6, 2004.
  30. Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PW, Guitreau DP, Pisters LL.  Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.  J Urol. 170(5):1868-71, 2003.
  31. Rosser CJ, Kuban DA, Levy LB, Pettaway CA, Chichakli R, Kamat AM, Sanchez-Ortiz RF, Pisters LL.  Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy.  J Urol. 170:1856, 2003.
  32. Tanaka M, Gee JR, DeLa Cerda J, Rosser CJ, Zhou JH, Benedict WF, Grossman HB.  Noninvasive detection of bladder cancer in an orthotopic murine model with green fluorescence protein cytology.  J Urol. 170(3):975-8, 2003.
  33. Rosser CJ, Slaton JW, Izawa JI, Levy LB, Dinney CP.  Clinical presentation and outcome of high-grade urinary bladder leiomyosarcoma in adults.  Urology. 61:1151, 2003.
  34. Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL.  Hazard Rates of Disease Progression after External-Beam Radiotherapy for Clinically Localized Carcinoma of the Prostate.  J Urol. 169(6): 2160-5, 2003.
  35. Rosser CJ, Kuban DA, Levy LB, Pettaway CA, Chichakli R, Kamat AM, Sanchez-Ortiz RF, Pisters LL.  Clinical Features and Treatment Outcome of Hispanic Men with Prostate Cancer following External-Beam Radiotherapy.  J Urol. 170(5): 1856-9, 2003.
  36. Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL.  Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma compared to localized radio-naive prostate carcinoma.  Int J Radiat Oncol Biol Phys. 56(1): 1-6, 2003.
  37. Rao A, Chang BL, Hawkins GA, Hu JJ, Rosser CJ, Hall MC, Meyers DA, Xu JF, Cramer SD.  Analysis of the G/A Polymorphism in the Androgen Response Element I of the PSA Gene and Its Interactions with Androgen Receptor Polymorphisms.  Urology: 61:864-869, 2003.
  38. Zhang X, Multani AS, Zhou JH, Shay JW, McConkey D, Dong L, Kim CS, Rosser CJ, Pathak S, Benedict WF.  Adenoviral-mediated Rentinoblastoma 94 Produces Rapid Telomere Erosion, Chromosomal Crisis, and Caspase-dependent Apoptosis in Bladder Cancer and Immortalized Human Urothelial Cells but not in Normal Urothelial Cells.  Cancer Res. 63, 760-765, Feb 2003.
  39. Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL.  Biochemical Disease-Free Survival in Men Younger than 60 Years with Prostate Cancer Treated by External-Beam Radiation.  J. Urol .168(2):536-41, Aug. 2002.
  40. Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL.  The PSA “Bounce” Phenomenon after External Beam Radiation for Clinically Localized Prostate Cancer.  J. Urol. 168(5), Nov. 2002.
  41. Yamashita M, Rosser CJ, Zhou J, Zhang X, Conner RJ, Engler H, Maneval DC, Karashima T, Czerniak BA, Dinney CPN, Benedict WF.  Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.  Cancer Gene Ther. 9(8):687-91, Aug. 2002.
  42. Zhou J, Rosser CJ, Tanaka M, Yang M, Baranov E, Hoffman RM, Benedict WF. Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression.  Cancer Gene Ther. 9(8):681-6, Aug. 2002.
  43. Rosser CJ, Benedict WF, Dinney CPN.  Gene Therapy for Superficial Bladder Cancer.  Exp Rev Anticancer Ther. 1:531-540, 2001.
  44. Rosser CJ, Hart L, McCullough D.  Urodynamic prognostic risk factors in patients with Parkinson Disease undergoing TURP.  Infections in Urology. 14(1):23-28, May/June 2001.
  45. Martin JH, Rosser CJ, Leinbach F, Patel S, Assimos DG, McCullough DL.  The Pre-operative utility of PT/PTT in patients undergoing percutaneous nephrostomy tube placement. Tech in Urol. 6(3):205-7, Sept 2000.
  46. Rosser CJ, McCullough D, Hall MC.  The utility of post-operative thoracostomy tubes in patients undergoing a thoracoabdominal nephrectomy. Urology.  55: 847-851, 2000.
  47. Rosser CJ, Zagoria R, Dixon R, Scurry WC, Bare RL, McCullough D, Assimos D.  Is there a learning curve phenomenon in diagnosing a ureteral calculus with non-contrast helical computed tomography?  Canadian Association of Radiology Journal.  51(3):177-81, June 2000.
  48. Rosser CJ, Morykways M, Bare R, Argenta L.  A New Treatment to Manage Perineal Wounds. Infections in Urology.  13(2): 45-47, 2000.
  49. Rosser CJ, Gerrard E.  Metastatic Small Cell Carcinoma to the Testicle.  Southern Medical Journal. 93(1):72-3, Jan 2000.
  50. Rosser CJ, Gerrard E.  Metastatic Adenocarcinoma of the Pancreas to the Testicle.  American Journal of Clinical Oncology.  22(6): 619-620, Dec 1999.
  51. Rosser CJ, Broberg J, Eskew LA, Case D, McCullough D.  Detection of Prostatic Intraepithelial Neoplasia with the five region biopsy technique. Urology.  54(5): 853-6, Nov. 1999.
  52. Rosser CJ, Scharling E, Assimos DG.  Leiomyoma of the Scrotum. Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157.  Digital Urology Journal.
  53. Rosser CJ, Bare RL, Hart L, Meredith JW.  The incidence of urosepsis in the intensive care unit patient.  American Journal of Surgery.  177(4): 287-90, April 1999.
  54. Potter L, Rosser CJ, Kroovand L.  Prune Belly and VATER association in a newborn infant.  Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157.  Digital Urology Journal.

Back to Top


Invited Articles
  1. Rosser CJ, Benedict JF, Zagoria R, Jarow JP.  Imaging of the Male Reproductive Tract for Infertility.  Atlas of Urologic Clinics of North America April 1999.

Back to Top


Book Chapters
  1. Rosser CJ, McCullough D. Penile Cancer.  Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157.  Cancer Consults.

Back to Top